Literature DB >> 33589592

Circular RNA circ_103820 suppresses lung cancer tumorigenesis by sponging miR-200b-3p to release LATS2 and SOCS6.

Yongbin Chi1, Wenlong Zheng2, Guangyu Bao3, Lifeng Wu4, Xiaoxue He1, Ruyi Gan1, Yan Shen1, Xudong Yin5, Mingming Jin6.   

Abstract

A growing number of circular RNAs (circRNAs) have been identified and verified in several cancers. However, highly efficient therapeutic methods based on circRNAs in lung cancer remain largely unexplored. In the present study, we identified a novel circular RNA, hsa_circ_103820, based on Gene Expression Omnibus (GEO) data. Functionally, overexpression of hsa_circ_103820 showed significant inhibitory effects on the proliferation, migration and invasion of lung cancer cells, and knockdown of hsa_circ_103820 played promoting roles. Regarding the mechanism, we revealed that miR-200b-3p was a direct target of hsa_circ_103820 and that LATS2 and SOCS6 were the downstream target genes of miR-200b-3p. Therefore, we identified a novel potential tumor suppressive function of hsa_circ_103820 in lung cancer.

Entities:  

Year:  2021        PMID: 33589592      PMCID: PMC7884777          DOI: 10.1038/s41419-021-03472-7

Source DB:  PubMed          Journal:  Cell Death Dis            Impact factor:   8.469


  32 in total

Review 1.  Surgery for limited-stage small-cell lung cancer.

Authors:  Hayley Barnes; Katharine See; Stephen Barnett; Renée Manser
Journal:  Cochrane Database Syst Rev       Date:  2017-04-21

Review 2.  Endogenous microRNA sponges: evidence and controversy.

Authors:  Daniel W Thomson; Marcel E Dinger
Journal:  Nat Rev Genet       Date:  2016-04-04       Impact factor: 53.242

3.  The biogenesis and emerging roles of circular RNAs.

Authors:  Ling-Ling Chen
Journal:  Nat Rev Mol Cell Biol       Date:  2016-02-24       Impact factor: 94.444

4.  SOCS6 Functions as a Tumor Suppressor by Inducing Apoptosis and Inhibiting Angiogenesis in Human Prostate Cancer.

Authors:  Dongbo Yuan; Wei Wang; Jiaming Su; Yongqiang Zhang; Boshi Luan; Haofu Rao; Tianfei Cheng; Wei Zhang; Shiwei Xiao; Mingsheng Zhang; Fu-Neng Jiang; Zhaolin Sun; Zhenyu Jia; Wei-De Zhong; Jianguo Zhu
Journal:  Curr Cancer Drug Targets       Date:  2018       Impact factor: 3.428

Review 5.  circRNAs in Cancer.

Authors:  Ines Lucia Patop; Sebastian Kadener
Journal:  Curr Opin Genet Dev       Date:  2017-12-12       Impact factor: 5.578

6.  Cortical Layer Inversion and Deregulation of Reelin Signaling in the Absence of SOCS6 and SOCS7.

Authors:  Isobel D Lawrenson; Danielle L Krebs; Edmond M Linossi; Jian-Guo Zhang; Tamara J McLennan; Caitlin Collin; Helen M McRae; Tatiana B Kolesnik; Katrina Koh; Joanne M Britto; Andrew J Kueh; Bilal N Sheikh; Farrah El-Saafin; Nicos A Nicola; Seong-Seng Tan; Jeffrey J Babon; Sandra E Nicholson; Warren S Alexander; Tim Thomas; Anne K Voss
Journal:  Cereb Cortex       Date:  2017-01-01       Impact factor: 5.357

7.  LATS1 and LATS2 suppress breast cancer progression by maintaining cell identity and metabolic state.

Authors:  Noa Furth; Ioannis S Pateras; Ron Rotkopf; Vassiliki Vlachou; Irina Rivkin; Ina Schmitt; Deborah Bakaev; Anat Gershoni; Elena Ainbinder; Dena Leshkowitz; Randy L Johnson; Vassilis G Gorgoulis; Moshe Oren; Yael Aylon
Journal:  Life Sci Alliance       Date:  2018-10-30

8.  Identification of Genetic Mutations in Cancer: Challenge and Opportunity in the New Era of Targeted Therapy.

Authors:  Jing Jin; Xu Wu; Jianhua Yin; Mingxing Li; Jing Shen; Jing Li; Yueshui Zhao; Qijie Zhao; Jingbo Wu; Qinglian Wen; Chi Hin Cho; Tao Yi; Zhangang Xiao; Liping Qu
Journal:  Front Oncol       Date:  2019-04-16       Impact factor: 6.244

9.  CircPTK2 (hsa_circ_0005273) as a novel therapeutic target for metastatic colorectal cancer.

Authors:  Hongbao Yang; Xiaobo Li; Qingtao Meng; Hao Sun; Shenshen Wu; Weiwei Hu; Guilai Liu; Xianjing Li; Yong Yang; Rui Chen
Journal:  Mol Cancer       Date:  2020-01-23       Impact factor: 27.401

10.  MiR-200b-3p Functions as an Oncogene by Targeting ABCA1 in Lung Adenocarcinoma.

Authors:  Keqiang Liu; Weiqiang Zhang; Jian Tan; Jingbo Ma; Jing Zhao
Journal:  Technol Cancer Res Treat       Date:  2019 Jan-Dec
View more
  6 in total

1.  Methyltransferase-like 3 facilitates lung cancer progression by accelerating m6A methylation-mediated primary miR-663 processing and impeding SOCS6 expression.

Authors:  Shengshu Li; Xiaoxin Lu; Dongyang Zheng; Weizong Chen; Yuzhu Li; Fang Li
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-30       Impact factor: 4.322

2.  LINC01088 regulates the miR-95/LATS2 pathway through the ceRNA mechanism to inhibit the growth, invasion and migration of gastric cancer cells.

Authors:  Zhuan Wen; Yong Li; Bibo Tan; Zihao Chen; Qun Zhao; Ming Tan; Yijie Zhao; Yuxiang Xia; Liqiao FanΔ
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.298

3.  MiR-330-5p and miR-1270 target essential components of RNA polymerase I transcription and exhibit a novel tumor suppressor role in lung adenocarcinoma.

Authors:  Sheetanshu Saproo; Shashanka S Sarkar; Ekta Gupta; Sourav Chattopadhyay; Aarzoo Charaya; Siddhant Kalra; Gaurav Ahuja; Srivatsava Naidu
Journal:  Cancer Gene Ther       Date:  2022-10-17       Impact factor: 5.854

Review 4.  Circular RNA and Its Roles in the Occurrence, Development, Diagnosis of Cancer.

Authors:  Yue Zhang; Xinyi Zhang; Yumeng Xu; Shikun Fang; Ying Ji; Ling Lu; Wenrong Xu; Hui Qian; Zhao Feng Liang
Journal:  Front Oncol       Date:  2022-04-07       Impact factor: 5.738

Review 5.  Role of circular RNAs in the diagnosis, regulation of drug resistance and prognosis of lung cancer.

Authors:  Chengpeng Sang; Dingyu Rao; Caixia Wu; Yao Xia; Maoyan Si; Zhixian Tang
Journal:  Oncol Lett       Date:  2022-07-07       Impact factor: 3.111

Review 6.  Regulatory functions of miR‑200b‑3p in tumor development (Review).

Authors:  Sheng Chen; Yifeng Tu; Hang Yuan; Zhan Shi; Yang Guo; Wenjing Gong; Shiliang Tu
Journal:  Oncol Rep       Date:  2022-03-24       Impact factor: 3.906

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.